MEG3 and anemia: For instance, it was confirmed that nasopharyngeal cancer patients undergoing chemotherapy with the CC genotype of lncRNA MEG3 had a significantly higher (threefold) probability of severe anemia (grades 3–4) (OR = 3.00; p = 0.007).